SINGAPORE & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, ...
As government and law enforcement agencies expand their digital infrastructure modernization efforts, maintaining compliance with the FBI's Criminal Justice Information Services (CJIS) Security Policy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback